Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,043 mentions
- robotic manipulationmarket824 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology491 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology371 mentions
- agentic AItechnology353 mentions
- vision-language-action modeltechnology350 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Vision-Language Modeltechnology318 mentions
- Microsoftorganization291 mentions
- Googleorganization276 mentions
- NVIDIAorganization264 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology175 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology169 mentions
- IBMorganization163 mentions
Entity
Dean Zikria
person10 mentionslast seen Nov 9, 2026
Interim Chief Executive Officer of Valion Bio.
Relationships 1
Relationship
Valion Bio, Inc.employsDean Zikria
99% confidence10 supporting mentions
Either name opens that entity’s relationships.
Sources 10
- filingSEC EDGARNov 9, 2026Valion Bio, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Title: Interim Chief Executive Officer
- filingSEC EDGARNov 2, 2026Valion Bio, Inc. 8-K: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer of Valion Bio
- filingSEC EDGAROct 29, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer of Valion Bio
- filingSEC EDGAROct 26, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer of Valion
- filingSEC EDGAROct 22, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Interim Chief Executive Officer Dean Zikria
- filingSEC EDGAROct 15, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer of Valion
- filingSEC EDGAROct 14, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer
- filingSEC EDGAROct 8, 2026Valion Bio, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 3.02: Unregistered Sales of Equity Securities; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Title: Interim Chief Executive Officer
- filingSEC EDGAROct 6, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Interim CEO Dean Zikria
- filingSEC EDGAROct 1, 2026Valion Bio, Inc. 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Dean Zikria, Interim Chief Executive Officer of Valion